跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Tamsulon-XL
Approved
STANDARD
Tamsulon-XL
Stallion Laboratories, Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7fcf3e72c40e5664
Company
Stallion Laboratories, Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
7fcf3e72c40e5664
Drug Approval Philippines Name
Tamsulon-XL
Product Name
Tamsulon-XL
Registration Number
DRP-8237
Brand Name
Tamsulon-XL
Generic Name
Tamsulosin Hydrochloride
Dosage Form
Prolonged-Release Capsule
Dosage Strength
400mcg
Manufacturer
Stallion Laboratories, Pvt. Ltd.
Importer
Ambica International Trading Corporation
Distributor
Ambica International Trading Corporation
Issuance Date
29 November 2023
Expiry Date
18 June 2029
Pharmacologic Category
Alpha-adrenoreceptor antagonists
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7fcf3e72c40e5664
Type
Standard
Back to Philippines FDA Approvals
Tamsulon-XL - Philippines FDA Drug Approval Details